Phase 1b News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase 1b. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase 1b Today - Breaking & Trending Today

Innate Pharma Provides Update on Lacutamab Clinical Program

MARSEILLE, France, October 05, 2023 Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the lacutamab IND leading to a pause in new patient enrollment to the Company’s ongoing lacutamab trials IPH4102-201 (Phase 2 TELLOMAK) and 102 (Phase 1b PTCL). The partial clinical hold follows one fatal case of hemophagocytic lymphohistiocytosis (HLH), a rare ....

United States , Henry Wheeler , Mondher Mahjoubi , Exchange Commission , French Financial Markets Authority , European Union , Drug Administration , European Medicines Agency , Company Annual Report On Form , Regulatory News , Euronext Paris , Innate Pharma , Chief Executive Officer , Fast Track , Engager Therapeutics , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , Annual Report , Euronext Paris , ézary Syndrome , Clinical Trials , Peripheralt Cell Lymphoma , Cutaneoust Cell Lymphoma , Cutaneous Lymphomas , Phase 1b ,

X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström's Macroglobulinemia at EHA 2021

Robust decreases in serum IgM at low- and mid-doses suggest best-in-class potential for mavorixafor plus ibrutinib therapy in double-mutation Waldenström’s patients; meaningful increases in hemoglobin levels suggest reduction in cancer burden in bone marrow At 6 months, patients achieved median IgM level reductions of 60%-75%, with one patient achieving normal IgM, and two of four patients (50%) had >50% reduction in IgM from baseline e-Poster now available online; pre-recorded presentation by l ....

Waldenströms Macroglobulinemia , Clinical Trial , Christian Buske , Phase 1b , X4 Pharmaceuticals ,

COVID Vaccine and Fertility, Pregnancy: The Latest Guidance


New guidance from the Centers for Disease Control and Prevention indicates a recent study found no obvious safety signals surrounding vaccination in pregnant women.
The researchers looked at data from 35,691 women, who ranged in age from 16 to 54, in a peer-reviewed study published this week in The New England Journal of Medicine. Data used in the research was self-reported using the v-safe after vaccination health checker, researchers noted.
No safety concerns were observed for people vaccinated in the third trimester or safety concerns for their babies, CDC Director Dr. Rochelle Walensky said Friday. As such, CDC recommends pregnant people receive COVID-19 vaccines. ....

United States , University Of Chicago , White House , District Of Columbia , Rochelle Walensky , Anthony Fauci , Allison Arwady , Regan Theiler , Centers For Disease , National Institutes Of Health , World Health Organization , Advisory Committee On Immunization Practices , Journal Of The American Medical Association , American College Of Obstetricians , Chicago Department Of Public Health , University Of Chicago Medicine , Disease Control , Recommended That Pregnant Women Receive , New England Journal , Advisory Committee , Immunization Practices , Chicago Medicine , American College , American Medical Association , Should Pregnant Women Consider Before Getting , Pregnant Women ,

Disability sector labels wait for COVID-19 vaccines 'shameful'


Disability sector labels wait for COVID-19 vaccines shameful
updated 4
The disability sector is frustrated at the lack of transparency over vaccine data.
(
Print text only
Cancel
As Australia enters its eighth week of the COVID-19 vaccine rollout, thousands of the nation s most vulnerable are still waiting for their first dose.
Key points:
One of Australia s largest disability service providers says they are yet to receive a single dose of coronavirus vaccines
Residents and workers in specialist disability accommodation were placed in Phase 1A of the rollout
At the end of March, vaccinations had been administered to 50 residential disability facilities
It is a situation leaders in the disability sector have labelled shameful , demanding to know when vaccines will be delivered. ....

Paul Kelly , Scott Morrison , Andrew Richardson , David Moody , National Disability Services , Medical Officer Paul Kelly , Disability Services , Minister Scott Morrison , Covid 19 , Corona Virus , Disability Sector , Phase 1b , பால் கெல்லி , ஸ்காட் மோரிசன் , ஆண்ட்ரூ ரிச்சர்ட்சன் , டேவிட் மனநிலை , தேசிய இயலாமை சேவைகள் , மருத்துவ அதிகாரி பால் கெல்லி , இயலாமை சேவைகள் , அமைச்சர் ஸ்காட் மோரிசன் , கொரோனா வைரஸ் , இயலாமை துறை ,